Equities

Provexis PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Provexis PLC

Actions
  • Price (EUR)0.013
  • Today's Change0.007 / 100.00%
  • Shares traded0.00
  • 1 Year change+766.67%
  • Beta0.5424
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Provexis plc is a United Kingdom-based company that develops, licenses and sells the proprietary, scientifically proven Fruitflow heart-health functional food ingredient. Fruitflow is a natural extract from tomatoes which has been shown in human trials to reduce the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can lead to heart attack and stroke. The extract is available as a spray-dried powder, and it can be included in a broad range of food, beverage and dietary supplement formats. Fruittflow is a highly concentrated form of bioactives which is lycopene-free and contains over 30 known antiplatelet compounds. The Company also offers Fruitflow+, Omega-3, and dietary supplement products which are sold directly to consumers. In addition, the Company supplies Fruitflow as an ingredient to brand owners in the food, beverage, and supplement sectors through DSM Nutritional Products’ distribution network.

  • Revenue in GBP (TTM)871.27k
  • Net income in GBP-603.80k
  • Incorporated2004
  • Employees2.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.